Milan, Italy

Giancarlo B Fregnan

This inventor holds 7 USPTO granted patents. Top assignees: Edmond Pharma, S.r.l., Istituto Luso Farmaco D'italia S.r.l., Instituto Luso Farmaco D'italia S.p.a.. Active years: 1976-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giancarlo B Fregnan. Retrieved from https://idiyas.com/inventor/giancarlo-b-fregnan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 1976-1996

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Giancarlo B Fregnan - Pioneering Inventor from Milan

Introduction: Giancarlo B Fregnan is a renowned inventor hailing from Milan, Italy, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Fregnan's latest patents include a revolutionary design for a sustainable energy generator and a cutting-edge medical device aimed at improving patient care and treatment outcomes.

Career Highlights: Throughout his illustrious career, Fregnan has received numerous accolades for his inventive spirit and has been recognized globally for his impactful inventions that have reshaped industries.

Collaborations: Fregnan has collaborated with leading research institutions, universities, and companies worldwide to further develop and implement his innovative ideas, showcasing his dedication to advancing technology and science.

Conclusion: Giancarlo B Fregnan's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…